Gilad Yahalom

1.9k total citations
55 papers, 1.1k citations indexed

About

Gilad Yahalom is a scholar working on Neurology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Gilad Yahalom has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 9 papers in Molecular Biology and 9 papers in Psychiatry and Mental health. Recurrent topics in Gilad Yahalom's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (13 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Gilad Yahalom is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (13 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Gilad Yahalom collaborates with scholars based in Israel, United States and Canada. Gilad Yahalom's co-authors include Sharon Hassin‐Baer, Simon Israeli‐Korn, Ben‐Ami Sela, David Tanné, Roseline Schwartz, Yvonne Schwammenthal, Oleg Merzeliak, David Orion, Noa Molshatzki and Avi Livneh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Gilad Yahalom

52 papers receiving 1.0k citations

Peers

Gilad Yahalom

NEURO

EPIDE

PHYSI

Kazushi Deguchi Japan

Wilson F. Abdo Netherlands

Kazutoshi Nishiyama Japan

Sabine Schädelin Switzerland

Rhys D. Brady Australia

A Marbini Italy

Konstantinos Paterakis Greece

Laura Papetti Italy

Vladimir Neychev United States

Stefan Braune Germany

Kazushi Deguchi Japan

Gilad Yahalom

289 ×0.6

NEURO

189 ×0.9

54 ×0.3

EPIDE

93 ×0.6

PHYSI

51 ×0.4

Citations per year, relative to Gilad Yahalom Gilad Yahalom (= 1×) peers Kazushi Deguchi

Countries citing papers authored by Gilad Yahalom

Since Specialization

Citations

This map shows the geographic impact of Gilad Yahalom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad Yahalom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad Yahalom more than expected).

Fields of papers citing papers by Gilad Yahalom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilad Yahalom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad Yahalom. The network helps show where Gilad Yahalom may publish in the future.

Co-authorship network of co-authors of Gilad Yahalom

This figure shows the co-authorship network connecting the top 25 collaborators of Gilad Yahalom. A scholar is included among the top collaborators of Gilad Yahalom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilad Yahalom. Gilad Yahalom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eichel, Roni, et al.. (2025). Comparison of Guided and Unguided Botulinum Injections for Cervical Dystonia: EMG, Ultrasound, and Anatomic Landmarks. CNS & Neurological Disorders - Drug Targets. 24(7). 546–553. 2 indexed citations

Horowitz, Mia, Volha Skrahina, Jan Lukáš, et al.. (2024). GBA1-Associated Parkinson’s Disease Is a Distinct Entity. International Journal of Molecular Sciences. 25(13). 7102–7102. 11 indexed citations

Yahalom, Gilad, et al.. (2024). Retrospective Comparison of Guided and Unguided Botulinum Neurotoxin Injections for Cervical Dystonia: Electromyography, Ultrasound, and Anatomic Landmarks. Toxicon. 237. 107437–107437. 1 indexed citations

Hassin‐Baer, Sharon, Oren Cohen, Simon Israeli‐Korn, et al.. (2022). Identification of an early-stage Parkinson’s disease neuromarker using event-related potentials, brain network analytics and machine-learning. PLoS ONE. 17(1). e0261947–e0261947. 14 indexed citations

Stelten, Bianca M. L., Maria Teresa Dotti, Aad Verrips, et al.. (2021). Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study. Orphanet Journal of Rare Diseases. 16(1). 353–353. 26 indexed citations

Israeli‐Korn, Simon, et al.. (2020). Visual self-motion cues are impaired yet overweighted during visual–vestibular integration in Parkinson’s disease. Brain Communications. 2(1). fcaa035–fcaa035. 30 indexed citations

Lerman, Sheera F., et al.. (2019). Catastrophizing mediates the relationship between non-motor symptoms and quality of life in Parkinson's disease. Disability and health journal. 12(4). 673–678. 10 indexed citations

Yahalom, Gilad, Lior Greenbaum, Simon Israeli‐Korn, et al.. (2018). Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations. Parkinsonism & Related Disorders. 62. 179–184. 60 indexed citations

Yahalom, Gilad, et al.. (2018). AppTUG - A Smartphone Application of Instrumented ‘Timed Up and Go’ for Neurological Disorders. 10(8). 689–695. 6 indexed citations

10.

Dobriyan, Alex, et al.. (2018). Three-Dimensional Orofacial Changes Occurring After Proportional Condylectomy in Patients With Condylar Hyperplasia Type 1B (Unilateral Hemimandibular Elongation). Journal of Oral and Maxillofacial Surgery. 77(4). 803–817. 11 indexed citations

11.

Yahalom, Gilad, Oren Cohen, Chen Sarbagili‐Shabat, et al.. (2016). The impact of early versus late levodopa administration. Journal of Neural Transmission. 124(4). 471–476. 6 indexed citations

12.

Yahalom, Gilad, et al.. (2015). Botulinum Toxin for Ocular Tics. 7(1). 9–11.

13.

Rahav, Galia, ‪Yasmin Maor‬‏, Gilad Yahalom, et al.. (2015). Primary Versus Nonprimary West Nile Virus Infection: A Cohort Study. The Journal of Infectious Diseases. 213(5). 755–761. 1 indexed citations

14.

Inzelberg, Rivka, Lior Greenbaum, Oren Cohen, et al.. (2014). The Melanocortin 1 Receptor (Mc1r) Variants Do Not Account for the Co-occurrence of Parkinson's Disease and Malignant Melanoma. Journal of Molecular Neuroscience. 54(4). 820–825. 9 indexed citations

15.

Yahalom, Gilad, et al.. (2014). Exploring determinants of progression in Parkinson's disease. Is there a difference among Jewish ethnic groups?. Parkinsonism & Related Disorders. 21(3). 184–188. 2 indexed citations

16.

Greenbaum, Lior, Stefano Goldwurm, Tzuri Lifschytz, et al.. (2013). Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study. Journal of Molecular Neuroscience. 51(2). 380–388. 9 indexed citations

17.

Yahalom, Gilad, et al.. (2013). Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid. Clinical Neuropharmacology. 36(3). 78–83. 93 indexed citations

18.

Ben‐Zvi, Ilan, et al.. (2012). Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.. PubMed. 14(4). 221–4. 11 indexed citations

19.

Yahalom, Gilad, Ilan Blatt, Miriam Y. Neufeld, Zeevi Dvir, & Revital Gandelman‐Marton. (2010). Epilepsy syndrome-associated balance dysfunction assessed by static posturography. Seizure. 20(3). 214–217. 4 indexed citations

20.

Yahalom, Gilad, Roseline Schwartz, Yvonne Schwammenthal, et al.. (2009). Chronic Kidney Disease and Clinical Outcome in Patients With Acute Stroke. Stroke. 40(4). 1296–1303. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact